From: Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
Gadoteridol | 0.1 mmol/kg or 0.2 ml/kg |
Gadoversetamide | 0.1 mmol/kg or 0.2 ml/kg |
Gadodiamide | CNS: 0.1 mmol/kg or 0.2 ml/kg |
Body: 0.05 mmol/kg or 0.1 ml/kg | |
Intrathoracic/intraabdominal/pelvic: 0.1 mmol/kg or 0.2 ml/kg | |
Gadobenate dimeglumine | 0.1 mmol/kg or 0.2 ml/kg |
Gadopentetate dimeglumine | 0.1 mmol/kg or 0.2 ml/kg |
Gadofosveset | 0.12 mmol/kg or 0.03 ml/kg |
Gadoxetate disodium | 0.025 mmol/kg or 0.1 ml/kg |
Gadoterate meglumine | 0.1 mmol/kg or 0.2 ml/kg |
Gadobutrol | 0.1 mmol/kg or 0.1 ml/kg |